A drug designed to help cancer patients rebuild wasting muscles has become one of the most contentious substances in elite sport – and the scientist who discovered it now spends more time trying to stop people using it than encouraging its medical use.
James Dalton, who developed ostarine in the early 2000s, recently told the New York Times: “I spend more time now trying to stop people from using it than trying to get people to use it.” His frustration highlights a growing crisis in anti-doping, where even innocent athletes are testing positive for a drug that can be transferred through sweat or contaminated supplements.
